| QIAGEN NV EO -,01 | 43,840 / +0,69% |
| Data / Laikas | 15.01. / 19:37 |
| Pok. / Pok.(%) | 0,300 / +0,69% |
| Bid | 43,840 |
| Ask | 44,000 |
| Atidaryti | 43,540 |
| Ankstesnį uždaryti | 43,540 |
| Aukšč. | 44,340 |
| Žem. | 43,520 |
| APYVARTA [EUR] | - |
| APYVARTA [Units] | |
| Price fixings | 2924 |
| ISIN | NL0012169213 |
| Simbolis | QIA |
| Birža | Lang & Schwarz |
| Rūšis | Stock |
Visos biržos
| Birža | Paskutinis | APYVARTA | |
|---|---|---|---|
| London Inter.. | 43,93 |  |
1.115.184 |
| Xetra | 44,060 | |
307.028 |
| NYSE | 53,20 | |
247.589 |
| Cboe Europe .. | 44,05 | |
143.769 |
| Turquoise | 44,04 | |
24.395 |
| TradeGate | 44,07 | |
13.266 |
| Cboe US | 53,20 | |
6.132 |
| Frankfurt | 44,0000 | |
6.125 |
| IEX | 53,30 | |
3.587 |
| Cboe Europe .. | 43,94 | |
1.914 |
| Stuttgart | 43,940 | |
1.400 |
| Cboe Europe .. | 43,93 | |
1.029 |
| Hamburg | 43,840 | |
640 |
| gettex | 44,050 | |
248 |
| Berlin | 43,930 | |
145 |
| Düsseldorf | 43,930 | |
60 |
| München | 43,900 | |
5 |
| Vienna Globa.. | 44,04 | |
0 |
| Hannover | 43,780 | |
0 |
| Lang & Schwa.. | 43,840 | |
|
| EUREX | Options | ||
Naujienos
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
09.12.2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
10.11.2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
06.10.2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
13.08.2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
11.08.2020 / 22:01 - GlobeNewswire